| Kylee Macdonald, | |
|
360 Summer St, Bristol, NH 03222-3213 | |
| (603) 744-2652 | |
| Not Available |
| Full Name | Kylee Macdonald |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 360 Summer St, Bristol, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497410609 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 08530621 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kylee Macdonald, 230 Ridge View Dr, Bristol, NH 03222-5413 Ph: () - | Kylee Macdonald, 360 Summer St, Bristol, NH 03222-3213 Ph: (603) 744-2652 |
News Archive
The UK-wide Good Garage Scheme has launched a new initiative to help garage owners better protect themselves against workshop accidents. The 3000-member organisation, backed by leading trade-only treatments company Forté, has launched a "health & safety support scheme" for member garages to help them fully understand the need to protect their business by putting proper health and safety policies in place.
Corathers Health Consulting, dedicated to the advancement of medical and surgical technologies, knows that insight from practitioners is especially critical to new product design.
Cadent, the leading provider of 3-D digital solutions for the orthodontic and dental industries, today celebrates the 10th anniversary of the introduction of OrthoCAD iCast™ digital study models.
Enzo Biochem, Inc. announced today a co-marketing partnership between its Enzo Life Sciences subsidiary, a world leader in non-radioactive probe technology, and BioTek Instruments, a privately held global leader in the development, manufacture and sale of microplate instrumentation for drug discovery and life science applications, involving powerful, integrated solutions for high throughput live cell analysis.
In a recent bioRxiv* preprint, the large team of researchers evaluated a SARS-CoV-2 Spike receptor-binding domain ferritin nanoparticle protein vaccine (RFN) in a nonhuman primate challenge model. This study addresses the need for a next-generation, efficacious vaccine with an increased pan-SARS breadth of coverage.
› Verified 3 days ago
Debra Lea England Stevens, APRN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 802 Lake St Unit B, Bristol, NH 03222 Phone: 603-530-2228 |